Jon Snodgres - Aug 1, 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Chief Financial Officer
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Aug 1, 2022
Transactions value $
-$440,000
Form type
4
Date filed
8/2/2022, 05:26 PM
Previous filing
May 17, 2022
Next filing
Aug 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Sale -$440K -2K -5.1% $220.00 37.2K Aug 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 9, 2022.